Other Events ·
On June 29, 2026, the Audit Committee of Praxis Precision Medicines, Inc. dismissed Ernst & Young LLP (EY) as its…
PRAXPraxis Precision Medicines, Inc.
On June 29, 2026, the Audit Committee of Praxis Precision Medicines, Inc. dismissed Ernst & Young LLP (EY) as its independent registered public accounting firm, effective immediately. The company has engaged KPMG LLP as its new independent registered public accounting firm, effective the same date. Previous audit reports from EY for the fiscal years 2024 and 2025 were not adverse, disclaimed, or qualified. Praxis Precision Medicines, Inc. is a biotechnology company focused on developing precision medicines for neurological disorders.